title: The Impact of Alternative Payment Models on Oncology Innovation and Patient Care.
abstract: Oncology care is in a time of major transformation. Scientific discovery is driving breakthroughs in prevention, diagnostics, and treatment, resulting in tremendous gains for patients as the number of cancer survivors continues to grow on an annual basis. At the same time, there is mounting pressure across the healthcare system to contain costs while improving the quality of cancer care. In response to this pressure, private and government payers are increasingly turning to tools such as alternative payment models (APM) and clinical pathways to improve the efficiency of care, inform coverage decisions, and support shared decision-making. As APMs, clinical pathways and other tools are utilized more broadly, it will be critical that these models support the evidence-based use of innovative biomedical advances, including personalized medicine, and deliver patient-centered, high-value care. Clin Cancer Res; 22(10); 2335-41. ©2016 AACR.
authors.affiliation: Personalized Medicine Coalition, Washington, District of Columbia.
authors.forename: Amy M
authors.initials: AM
authors.lastname: Miller
authors.affiliation: Department of Computational Medicine & Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan. Health Policy Committee, American Association for Cancer Research, Philadelphia, Pennsylvania.
authors.forename: Gilbert S
authors.initials: GS
authors.lastname: Omenn
authors.affiliation: Feinstein Kean Healthcare, Cambridge, Massachusetts. marcia.kean@fkhealth.com.
authors.forename: Marcia A
authors.initials: MA
authors.lastname: Kean
mesh_terms: D003657:Decision Making; D003695:Delivery of Health Care / Q000191:economics; D006801:Humans; D008495:Medical Oncology / Q000191:economics*; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics* / Q000628:therapy; D005791:Patient Care / Q000191:economics*; D057285:Precision Medicine / Q000191:economics